The Ensuring Pathways to Innovative Cures Act would extend the time Medicare can negotiate and set prices for small molecule drugs after an initial FDA approval. Here's why that's important.

A small molecule shaped like a lasso may be a powerful tool in the fight against infectious diseases, according to a new ...

The new center will design novel drug-like molecules using generative AI and optimize existing compounds to enhance their ...

New York City-based The Icahn School of Medicine at Mount Sinai has established a new research center focused on using AI to ...

This evolving landscape is tightening its grip on an industry already struggling to keep pace with patient demand, and small molecule drug developers are feeling the pinch most acutely.

WALTHAM, Mass.--(BUSINESS WIRE)--Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced ...

An oral small molecule from New York-based biotech Oligomerix curbed the tangling of tau protein in the brains of mice that model a rare neurological disease. The results, published on March 12 in ...